GNFT News and Press, GENFIT S.A. From 07/23/25

2025-07-23 18:45:50 ET Genfit S.A. (GNFT) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.51%. The average open to low on the day of earnings was -2.07%. The average open to close on t...

2025-05-26 10:32:36 ET Summary Despite a sharp decline in sales of COVID-19 blockbuster Veklury, Gilead Sciences once again beat consensus revenue and EPS forecasts. The drugs whose performance impressed me greatly in Q1 2025 and which played a key role in maintaining Gilead's EBI...

2025-05-12 13:19:58 ET Summary Genfit's Iqirvo, approved for PBC, generated $26M in Q1 2025, but faces competition from Gilead’s Livdelzi, limiting its market potential. Genfit's focus is now on developing drugs for ACLF, a high-risk area with no approved treatments, making...

Mountain Valley MD Holdings Inc (MVMDF) is expected to report for quarter end 2024-12-31 Yunji Inc. (YJ) is expected to report for quarter end 2024-12-31 UpHealth Inc. (UPHL) is expected to report for quarter end 2024-12-31 Fisker Inc. Class A (FSRNQ) is expected to report for quarter...

2025-04-02 18:44:29 ET Genfit S.A. (GNFT) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in GNFT stock price following earnings has averaged ±1.85% , with a median of 1.64%. The sing...

2025-02-21 03:53:07 ET More on Genfit Seeking Alpha’s Quant Rating on Genfit Historical earnings data for Genfit Financial information for Genfit Read the full article on Seeking Alpha For further details see: Genfit reports preliminary res...